Trending Now
Citius Pharmaceuticals Inc. (NASDAQ:CTXR) CEO Presents Update On Mino-Lok Study At...
Citius Pharmaceuticals Inc. (NASDAQ:CTXR) has announced that its CEO Myron Holubiak will offer a virtual presentation at the Life Sciences Investors Forum, including an...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
SPY bounces back (AAPL,XLE,XLF)
Markets had a rough morning and have bounced back nicely, looking to end the day relatively flat. This creates a doji type...
MAKE IT MODERN
LATEST REVIEWS
Seattle Genetics Inc. (NASDAQ:SGEN) Enters Two Oncology Collaboration Agreements With Merck...
Seattle Genetics Inc. (NASDAQ:SGEN) and Merck (NYSE:MRK) have entered two new strategic oncology partnerships for co-development and global commercialization of Ladiratuzumab Vedotin and co-development...
MAKE IT MODERN
PERFORMANCE TRAINING
Seelos Therapeutics Inc.’s (NASDAQ: SEEL) SLS-005 Included in the HEALEY ALS Platform Trial
The Sean M. Healey & AMAG Centre for ALS at Mass General has received FDA approval, and The Mass General Brigham Institutional Review Board...
Is the surge in G Medical Innovations Holdings (GMVD) justified
G Medical Innovations Holdings Ltd (NASDAQ:GMVD) surged more than 80% today and closed the day at $5.41. The stock opened at $5.94...
Galectin Therapeutics Inc. (NASDAQ: GALT) Announces Results From Phase 1b Clinical Trial
Galectin Therapeutics Inc. (NASDAQ: GALT), the developer of therapeutics that target galectin proteins, announced the results from its Phase 1b clinical trial of Belapectin.
Extension...
Pharmaceutical Giants Navigate Market Tides: A Glimpse into the Future of Healthcare Investment (ATNM)
In the fast-paced realm of the stock market, the pharmaceutical sector continues to be a beacon for investors, blending the promise...
Innoviva Inc. Submits Proposal To Acquire All Outstanding Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX)...
Entasis Therapeutics Holdings Inc.’s (NASDAQ: ETTX) Board of Directors has received an interim, non-binding proposal from Innoviva Inc., its majority shareholder, to purchase all...
MAKE IT MODERN
